Alkaline Phosphatase Levels Predict AKI in Paediatric Sepsis

A recent multicentre retrospective study has identified serum alkaline phosphatase levels as a potential clinical predictor for acute kidney injury (AKI) in paediatric patients suffering from sepsis. The study, which evaluated patient data across multiple medical centres, suggests that monitoring these enzyme levels can assist clinicians in identifying children at high risk for renal complications. Early detection is vital in paediatric intensive care, where sepsis remains a leading cause of multi-organ failure and prolonged hospital stays.

Sepsis-induced AKI in children is a challenging clinical scenario that requires rapid response to prevent permanent renal damage. Historically, clinicians have relied on traditional creatinine-based measurements, which may often delay diagnosis due to their lag in reflecting rapid changes in kidney function. By utilizing serum alkaline phosphatase as a supplementary biomarker, healthcare teams can potentially detect renal injury earlier in the progression of sepsis, allowing for more proactive and targeted therapeutic interventions.

These findings highlight the importance of expanding the diagnostic toolkit for critical paediatric care. Implementing routine biomarker screening in sepsis protocols could standardize care across Indian hospitals and improve survival outcomes for vulnerable children. Future research is now required to validate these predictive capabilities in larger, more diverse prospective patient populations. As pediatric nephrology advances, such clinical insights serve as a critical bridge between laboratory research and bedside decision-making to optimize patient outcomes.